Primera terapia car-T para tumores sólidos: Jicc proporciona acceso a pacientes de todo el mundo PR Newswire (Press Release) 11:46
Première autorisation au monde d'un traitement par cellules car-T contre les tumeurs solides : le Centre international de cancérologie Jiahui est accessible aux patients du monde entier PR Newswire (Press Release) 11:46
World's First Solid Tumor car-T Approved: Jiahui International Cancer Center Provides Access for Patients Worldwide PR Newswire (Press Release) 09:57 Wed, 24 Jun
Wearable Devices May Help Detect Cytokine Release Syndrome Earlier in Patients Receiving CAR-T Therapy Newswise (Press Release) 19:29 Mon, 22 Jun
Dr. Theodore Scott Nowicki receives grant to advance novel CAR-T therapy for pediatric bone cancer Newswise (Press Release) 18:46 Mon, 22 Jun
Breakthrough: China’s First Approved Solid Tumor car-T Therapy Paves the Way for Industry Transformation China Money Network 15:35 Mon, 22 Jun
AbClon, GC Biopharma partner on in vivo CAR-T using proprietary antibody Korea Biomedical Review 09:44 Wed, 17 Jun
EHA 2026: Legend Impresses With Early In Vivo CAR-T Results In Lymphoma Scrip Pharma Intelligence 10:29 Mon, 15 Jun
Curocell reports published phase 2 results for approved CAR-T therapy Korea Biomedical Review 05:20 Mon, 15 Jun
Legend Biotech (LEGN) Is Up 6.1% After Early In Vivo CAR-T Data for LB2501 – What's Changed Simply Wall St 10:26 Fri, 12 Jun
T-CURX Non-Viral Siglec-6 Lead CAR-T Program, TCX-001, Was Approved for First-In-Human Phase 1 Clinical Trial in Patients with Relapsed/Refractory AML and CLL Biotech, B3C newswire 09:07 Thu, 11 Jun
Cartesian Therapeutics Shares Jump 24% On Strategic car-T Licensing Agreement RTT News 16:25 Tue, 09 Jun
OriCell's GPC3 car-T Receives NMPA Clearance for Confirmatory Phase II Trial in Late-Line Advanced Hepatocellular Carcinoma PR Newswire (Press Release) 01:14 Mon, 08 Jun
Car-T therapy brings hope to kidney patients with few transplant options Rock Hill Herald 17:06 Fri, 05 Jun Article paywall
Early Complete Response Following CAR-T Therapy Predicts Sustained Remission in LBCL Hematology Advisor 14:36 Fri, 05 Jun
Non-gene-edited, CD19-targeted, allogeneic car-T cell therapy for relapsed or refractory B-cell acute lymphoblastic leukemia: an open-label, single-arm phase 1 study Nature.com 02:15 Thu, 04 Jun
New clinical trial finds car-T therapy could also help treat kidney failure CBS Philadelphia 22:48 Wed, 03 Jun
‘Transformative’ car-T therapy allows three people to receive kidney transplants Nature.com 22:03 Wed, 03 Jun
CAR-T cell therapy shows promise for treating rheumatoid arthritis News-Medical.Net 19:11 Wed, 03 Jun
Evolving landscape of targeted immunotherapeutic interventions and car-T therapy for acute myeloid leukemia Nature.com 18:13 Wed, 03 Jun
With Cencora pact, Gilead looks to grow CAR-T treatment center network FiercePharma 16:17 Wed, 03 Jun
Bispecific Antibodies Associated With Lower Early Immune-Mediated Toxicity Compared With CAR-T Therapy in DLBCL, FL Hematology Advisor 18:20 Tue, 02 Jun
ASCO 2026: Kelonia presents positive in vivo CAR-T data in multiple myeloma Pharmaceutical Technology 17:13 Tue, 02 Jun
AvenCell Therapeutics to Report Phase 1a Results of First-in-Class Switchable Allogeneic CD123 car-T Therapy for AML in Late-Breaking oral presentation at Eha 2026 PR Newswire (Press Release) 14:32 Tue, 02 Jun
T-CURX acquires Pantherna Therapeutics to fast-track non-viral in vivo CAR-T pipeline Manufacturing Chemist 15:45 Mon, 01 Jun
T-CURX Acquires Pantherna Therapeutics to Accelerate Clinical Translation of its Non-Viral In Vivo CAR-T Strategies Biotech, B3C newswire 08:03 Mon, 01 Jun
ASCO 2026 | Oricell's GPC3 car-T Ori-C101 Hits 66.7% Orr in Late-Line HCC, Signaling Best-in-Class Potential PR Newswire (Press Release) 03:42 Mon, 01 Jun
Kelonia Therapeutics Presents Updated First-in-Human Data from Phase 1 inMMyCAR Study of Kln-1010 in vivo Bcma car-T Therapy at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting Business Wire (Press Release) 13:05 Sun, 31 May
Cardiotoxicity induced by multiple myeloma therapies: mechanistic convergence across proteasome inhibitors, car-T, and bispecific antibodies Nature.com 16:07 Fri, 29 May
Imugene targets blood cancer with off-the-shelf CAR-T - ICYMI Proactive Investors (Australia) 02:08 Fri, 29 May
Curocell to retry CAR-T Rimqarto reimbursement in July after first HIRA setback Korea Biomedical Review 02:29 Thu, 28 May
Tata-backed MedTherapy claims car-T breakthrough with one-day production The Economic Times 16:07 Wed, 27 May
MedTherapy bets on low-cost car-T manufacturing with Noida Cdmo push The Business Standard 14:29 Wed, 27 May
Understanding the potential of car-T therapy in autoimmune disease treatment The Hindu 03:31 Wed, 27 May Article paywall
King's College London spins out Korecyte Bio Ltd with investment and support from Cell and Gene Therapy Catapult to advance novel CAR-T platform for solid tumours King's College London 10:52 Tue, 26 May
